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ABSTRACT
Bell’s Palsy is the sudden onset of unilateral temporary paralysis of facial muscles resulting from sev-
enth cranial nerve dysfunction. Presented here is a two-year old female patient with right peripheral 
facial palsy following hepatitis B vaccination. Readers’ attention is drawn to an uncommon cause of 
Bell’s Palsy, as a rare complication of hepatitis B vaccination.
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INTRODUCTION
Bell’s Palsy is the sudden onset of unilateral tem-
porary paralysis of facial muscles, resulting from 
seventh cranial nerve dysfunction. Bell’s Palsy has a 
frequency of 20/100,000 individuals per year, and a 
recurrence rate of 9% of cases. Although Bell’s Palsy 
is a well-known and relatively-common disease, its 
aetiology is still unclear (1-3). Following the intro-
duction of hepatitis B vaccination, rare serious re-
actions, such as demyelinating myelitis, demy-
elinations of the peripheral and central-nervous 
system, vasculitis, auto-immune diseases, Bell’s 
Palsy, and opthalmological abnormalities, have 
been described (4-12). We would like to draw the 
reader’s attention to a possible cause of Bell’s Palsy 
as a rare complication of hepatitis B vaccination.
Case report
On 10 May 2004, a two-year old female patient 
was admitted to the paediatric department, Medi-
cal Faculty, Ataturk University, because of a right 
peripheral facial palsy. On admission, the child 
looked well, and she had no fever. There was no 
history of an upper respiratory tract infection. Car-
diovascular, respiratory, abdominal and otoscopic 
examinations were all normal. She had Bell’s sign 
on the right side of her face. There was no involve-
ment of other cranial nerves, and the remainder of 
neurologic examination was normal.
Haematological and urine analyses were normal. 
Magnetic resonance imaging of brain demonstrated 
no abnormality, and blood serology was negative 
for Epstein-Barr virus, cytomegalovirus, herpes sim-
plex virus, rubella, toxoplasma, and Mycoplasma 
pneumoniae. Six days before admission, she had 
been given recombinant hepatitis B vaccine. Bell’s 
Palsy was thought most probably to be a sequel of 
vaccination against hepatitis B. No treatment was 
given, and her symptoms improved spontaneous-
ly. The patient began to improve on the 22nd day 
after the onset of symptoms, and 90 days after pres-
entation, Bell’s Palsy had completely resolved.
DISCUSSION
Over the past 30 years, representatives of the 
medical establishment have discussed and warned 
about neurologic complications of various vaccines 
(13-16). Vaccination against hepatitis B virus (HBV) 
is important to reduce the incidence of HBV-asso-
ciated infection. Although HBV vaccine is among 
the safest of all vaccines, it has been associated with 
adverse effects (8-12,17). Shaw et al. reported a post-
marketing surveillance study, recording neurologic 
events after hepatitis B vaccination (11). An esti-
mated 850,000 individuals had received the vac-
cine over the time of their study. They found three 
cases of brachial plexus neuropathy, four cases of 
transverse myelitis, five cases of optic neuritis, five 
cases of lumbar radiculopathy, nine cases of Gul-
lian-Barre Syndrome, and 10 cases of Bell’s Palsy. Alp H et al. Bell’s Palsy due to hepatitis B vaccination
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Seven hundred reports of adverse reactions to the 
hepatitis B vaccine were sent into the Vaccine Ad-
verse Events Reporting Systems (VAVERS). Sixteen 
percent of these reports were of damage presumed 
to be to the myelin of the nervous system. There 
were 21 cases of facial paralysis (17). 
The aetiology and pathogenesis of Bell’s Palsy re-
mains unclear. There is a concern that reactivation 
of latent herpes simplex virus-associated infections 
of the geniculate ganglia of facial nerves may be 
one of the causes of Bell’s Palsy. Auto-immune proc-
esses have also been considered (18-19). It has been 
hypothesized that an immunomediated segmental 
demyelination may be involved. Also, it is known 
that hepatitis vaccine is associated with Gullian-
Barre Syndrome and demyelinating disease, pos-
sibly through an immune response mechanism 
(9-12,17). Therefore, it is at least theoretically possi-
ble that hepatitis B vaccines may trigger Bell’s Palsy 
through  a smilar mechanism, although there is no 
current evidence to support this theory. We did not 
find any of the classical aetiologies of Bell’s Palsy in 
our patient. The sole cause suspected was the vac-
cination against hepatitis B six days before the di-
agnosis of this disease.
The prognosis in this disorder is excellent. More 
than 85% of cases recover spontaneously with no 
residual facial weakness as in our case; only 5% are 
left with permanent severe facial weakness (1,2). 
Further studies are needed to confirm wheth-
er hepatitis B vaccines are associated with an in-
creased risk of Bell’s Palsy and, if so, to investigate 
details of the pathogenesis. Also, we are conducting 
a population-based controlled study to determine 
whether this association is causal or co-incidental. 
We conclude that Bell’s Palsy must be considered in 
all patients with this disease, following hepatitis B 
vaccination but the present universal vaccination 
programme to eradicate hepatitis B should not be 
changed.
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